Jason Gerberry
Stock Analyst at Bank of America Securities
(4.94)
# 159
Out of 4,673 analysts
906
Total ratings
64.1%
Success rate
23.2%
Average return
Main Sectors:
Stocks Rated by Jason Gerberry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LLY Eli Lilly and Company | Maintained: Buy | $1,344 | $1,255.40 | +7.06% | 19 | Aug 21, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $141 → $166 | $152.55 | +8.82% | 20 | Aug 19, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $86 | $66.70 | +28.94% | 16 | Aug 18, 2026 | |
| AMLX Amylyx Pharmaceuticals | Reiterated: Buy | $22 → $39 | $38.66 | +0.88% | 4 | Aug 18, 2026 | |
| LQDA Liquidia | Reiterated: Hold | $79 → $92 | $68.62 | +34.07% | 20 | Aug 12, 2026 | |
| LENZ LENZ Therapeutics | Downgraded: Hold | $31 → $7 | $4.68 | +49.57% | 13 | Aug 12, 2026 | |
| MLYS Mineralys Therapeutics | Rated: Buy | $49 | $25.65 | +91.03% | 3 | Aug 12, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | $307 | $254.28 | +20.73% | 73 | Aug 10, 2026 | |
| AXSM Axsome Therapeutics | Reiterated: Buy | $276 | $207.77 | +32.84% | 30 | Aug 10, 2026 | |
| GUTS Fractyl Health | Reiterated: Buy | $2 | $0.78 | +156.41% | 15 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $20 | $21.60 | -7.41% | 17 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $77 | $60.77 | +26.71% | 16 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $32 | $13.09 | +144.55% | 19 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $41 | $54.08 | -24.19% | 36 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $133 | $62.62 | +112.39% | 31 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $87.11 | +14.80% | 23 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $26 → $27 | $28.07 | -3.81% | 13 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $28 → $30 | $38.15 | -21.36% | 17 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $71 | $67.01 | +5.95% | 15 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $276 | $264.96 | +4.17% | 15 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $41 | $37.34 | +9.80% | 83 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 → $93 | $59.74 | +55.67% | 47 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $38 | $48.33 | -21.37% | 42 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $263 | $270.24 | -2.68% | 13 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $10 → $14 | $16.32 | -14.22% | 41 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $626 → $613 | $513.12 | +19.47% | 20 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $61.31 | - | 8 | Jul 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $89 | $72.70 | +22.42% | 21 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $43 | $44.37 | -3.09% | 18 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $6.89 | $8.82 | -21.92% | 20 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $13.75 | - | 15 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $1 | $1.61 | -37.89% | 11 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $13.85 | -27.80% | 13 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $24.92 | - | 1 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $25 → $28 | $28.80 | -2.78% | 18 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $19.44 | -22.84% | 18 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.42 | n/a | 7 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.09 | n/a | 6 | Sep 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $4 → $3.5 | $1.85 | n/a | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $4 → $2 | $7.52 | n/a | 10 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $5 → $1 | $0.7201 | n/a | 4 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $10.20 | n/a | 1 | May 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $26 → $10 | $4.82 | n/a | 2 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $36.43 | n/a | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $110 | $236.22 | n/a | 1 | Nov 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $6 | $0.0001 | n/a | 3 | Aug 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $137.95 | n/a | 2 | Jun 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $9 | $1.22 | n/a | 1 | Oct 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $18 | $3.89 | n/a | 7 | Nov 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 | $0.3182 | n/a | 13 | Nov 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $59 → $37 | $24.67 | n/a | 7 | Nov 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $110 → $81 | $14.25 | n/a | 9 | Aug 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $33 → $24 | $17.91 | n/a | 7 | Aug 9, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $46.74 | n/a | 1 | Aug 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $14 | $4.29 | n/a | 9 | Aug 5, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 | $152.57 | n/a | 1 | Jul 13, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0012 | n/a | 3 | Jan 19, 2016 |
Eli Lilly and Company
Aug 21, 2026
Maintained: Buy
Price Target: $1,344
Current: $1,255.40
Upside: +7.06%
Merck & Co.
Aug 19, 2026
Reiterated: Buy
Price Target: $141 → $166
Current: $152.55
Upside: +8.82%
BioMarin Pharmaceutical
Aug 18, 2026
Maintained: Buy
Price Target: $86
Current: $66.70
Upside: +28.94%
Amylyx Pharmaceuticals
Aug 18, 2026
Reiterated: Buy
Price Target: $22 → $39
Current: $38.66
Upside: +0.88%
Liquidia
Aug 12, 2026
Reiterated: Hold
Price Target: $79 → $92
Current: $68.62
Upside: +34.07%
LENZ Therapeutics
Aug 12, 2026
Downgraded: Hold
Price Target: $31 → $7
Current: $4.68
Upside: +49.57%
Mineralys Therapeutics
Aug 12, 2026
Rated: Buy
Price Target: $49
Current: $25.65
Upside: +91.03%
Jazz Pharmaceuticals
Aug 10, 2026
Maintained: Buy
Price Target: $307
Current: $254.28
Upside: +20.73%
Axsome Therapeutics
Aug 10, 2026
Reiterated: Buy
Price Target: $276
Current: $207.77
Upside: +32.84%
Fractyl Health
Aug 10, 2026
Reiterated: Buy
Price Target: $2
Current: $0.78
Upside: +156.41%
Aug 7, 2026
Reiterated: Sell
Price Target: $20
Current: $21.60
Upside: -7.41%
Aug 7, 2026
Reiterated: Buy
Price Target: $77
Current: $60.77
Upside: +26.71%
Aug 7, 2026
Reiterated: Buy
Price Target: $35 → $32
Current: $13.09
Upside: +144.55%
Aug 5, 2026
Reiterated: Sell
Price Target: $41
Current: $54.08
Upside: -24.19%
Aug 5, 2026
Reiterated: Buy
Price Target: $133
Current: $62.62
Upside: +112.39%
Aug 4, 2026
Reiterated: Buy
Price Target: $100
Current: $87.11
Upside: +14.80%
Aug 4, 2026
Reiterated: Hold
Price Target: $26 → $27
Current: $28.07
Upside: -3.81%
Aug 4, 2026
Reiterated: Sell
Price Target: $28 → $30
Current: $38.15
Upside: -21.36%
Aug 3, 2026
Reiterated: Buy
Price Target: $71
Current: $67.01
Upside: +5.95%
Jul 31, 2026
Maintained: Buy
Price Target: $276
Current: $264.96
Upside: +4.17%
Jul 30, 2026
Reiterated: Buy
Price Target: $40 → $41
Current: $37.34
Upside: +9.80%
Jul 29, 2026
Reiterated: Buy
Price Target: $90 → $93
Current: $59.74
Upside: +55.67%
Jul 28, 2026
Reiterated: Sell
Price Target: $38
Current: $48.33
Upside: -21.37%
Jul 28, 2026
Reiterated: Hold
Price Target: $263
Current: $270.24
Upside: -2.68%
Jul 10, 2026
Reiterated: Sell
Price Target: $10 → $14
Current: $16.32
Upside: -14.22%
Jul 10, 2026
Reiterated: Hold
Price Target: $626 → $613
Current: $513.12
Upside: +19.47%
Jul 10, 2026
Maintained: Buy
Price Target: n/a
Current: $61.31
Upside: -
Jul 8, 2026
Maintained: Buy
Price Target: $89
Current: $72.70
Upside: +22.42%
May 21, 2026
Maintained: Buy
Price Target: $32 → $43
Current: $44.37
Upside: -3.09%
Feb 18, 2026
Reiterated: Sell
Price Target: $6.89
Current: $8.82
Upside: -21.92%
Feb 13, 2026
Maintained: Sell
Price Target: n/a
Current: $13.75
Upside: -
Jan 12, 2026
Maintained: Sell
Price Target: $1
Current: $1.61
Upside: -37.89%
Nov 10, 2025
Reiterated: Hold
Price Target: $10
Current: $13.85
Upside: -27.80%
Nov 7, 2025
Maintained: Sell
Price Target: n/a
Current: $24.92
Upside: -
Nov 6, 2025
Reiterated: Sell
Price Target: $25 → $28
Current: $28.80
Upside: -2.78%
Nov 6, 2025
Reiterated: Buy
Price Target: $15
Current: $19.44
Upside: -22.84%
Oct 30, 2023
Rated: Hold
Price Target: n/a
Current: $1.42
Upside: n/a
Sep 28, 2023
Rated: Hold
Price Target: n/a
Current: $2.09
Upside: n/a
Aug 9, 2023
Maintained: Sell
Price Target: $4 → $3.5
Current: $1.85
Upside: n/a
Aug 8, 2023
Downgraded: Sell
Price Target: $4 → $2
Current: $7.52
Upside: n/a
Jan 5, 2023
Maintained: Sell
Price Target: $5 → $1
Current: $0.7201
Upside: n/a
May 17, 2022
Maintained: Buy
Price Target: $11
Current: $10.20
Upside: n/a
Jul 15, 2020
Downgraded: Hold
Price Target: $26 → $10
Current: $4.82
Upside: n/a
Mar 11, 2020
Initiated Coverage: Buy
Price Target: $32
Current: $36.43
Upside: n/a
Nov 13, 2019
Initiated Coverage: Buy
Price Target: $110
Current: $236.22
Upside: n/a
Aug 20, 2019
Maintained: Buy
Price Target: $5 → $6
Current: $0.0001
Upside: n/a
Jun 28, 2019
Downgraded: Sell
Price Target: n/a
Current: $137.95
Upside: n/a
Oct 16, 2018
Downgraded: Sell
Price Target: $9
Current: $1.22
Upside: n/a
Nov 20, 2016
Reiterated: Buy
Price Target: $14 → $18
Current: $3.89
Upside: n/a
Nov 15, 2016
Reiterated: Buy
Price Target: $34
Current: $0.3182
Upside: n/a
Nov 2, 2016
Reiterated: Hold
Price Target: $59 → $37
Current: $24.67
Upside: n/a
Aug 10, 2016
Reiterated: Hold
Price Target: $110 → $81
Current: $14.25
Upside: n/a
Aug 9, 2016
Reiterated: Hold
Price Target: $33 → $24
Current: $17.91
Upside: n/a
Aug 8, 2016
Maintained: Hold
Price Target: n/a
Current: $46.74
Upside: n/a
Aug 5, 2016
Reiterated: Hold
Price Target: $10 → $14
Current: $4.29
Upside: n/a
Jul 13, 2016
Maintained: Buy
Price Target: $70
Current: $152.57
Upside: n/a
Jan 19, 2016
Downgraded: Hold
Price Target: n/a
Current: $0.0012
Upside: n/a